Velg regionen som passer best for din plassering eller dine preferanser.
Denne innstillingen kontrollerer språket for brukergrensesnittet, inkludert knapper, menyer og all tekst på nettstedet. Velg ditt foretrukne språk for best brukeropplevelse.
Velg språkene for stillingsannonser du vil se. Denne innstillingen bestemmer hvilke stillingsannonser som vises for deg.
Last application date May 18, 2025 00:00
Department LA24 - Department of Green Chemistry and Technology
Contract Limited duration
Degree Master's degree in bioscience engineering, chemical engineering, pharmaceutical engineering, mathematical engineering, environmental engineering or equivalent.
Occupancy rate 100%
Vacancy type Research staff
The Sustainable Systems Engineering (STEN) group and the research units BIONAMIX and BIOVISM of Ghent University welcome a candidate for a full time PhD position on advancing prospective sustainability assessments of pharmaceutical manufacturing via data-driven and hybrid methods. The PhD student will be appointed within the framework of the European project PHARMECO (Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing) (https://pharmeco.eu/), involving academia, research institutes, pharmaceutical industry and consultancy.
The PHARMECO project aims to scale up and demonstrate sustainable processes for industrial (bio)manufacturing of pharmaceuticals by integrating environmentally friendly technologies and processes. However, given the complexity of production processes, there is still a knowledge gap on the environmental impact of, for example, pharmaceutical biomanufacturing. Prospective sustainability assessment of pharmaceuticals in early development stages is especially challenging due to limited data availability, making it difficult to predict environmental impacts accurately. Additionally, complex synthesis routes require integrating green chemistry and life cycle thinking in early decision-making. AI-based methods and hybrid models, which integrate data-driven and mechanistic modelling, hold significant potential to enhance prospective sustainability assessment of pharmaceuticals by enabling early-stage prediction of environmental impacts, optimizing synthetic pathways, and supporting data-driven decision-making for greener drug development.
Within your PhD, you will develop a methodological approach which leverages the power of data-driven and hybrid methods for the prospective sustainability assessment of pharmaceuticals at early development stages. Several sub-objectives have been identified:
In this PhD position, you will work in close collaboration with other STEN and KERMIT colleagues at Ghent University and the PHARMECO consortium, in particular with the industrial partners such as Johnson & Johnson/Janssen Pharmaceutica, Sanofi, Pfizer, Merck, UCB, GSK, Novo Nordisk and AstraZeneca. The scientific findings should lead to publications in international peer reviewed journals and should be presented at international conferences. The ultimate goal of the research is to obtain a doctoral degree.
The start date is planned at August or September 1st 2025. The PhD duration is four years.
Candidates are expected to have a background in engineering and/or an affinity for mathematical modelling and sustainability assessment methods such as life cycle assessment. Affinity with pharmaceutical manufacturing or chemical processes is also relevant. We are looking for candidates with a critical and analytical attitude and a sense of initiative.
Other profile requirements:
Send your CV, copy of your diploma (if already in your possession) and a motivation letter to [email protected].
We do not accept late applications.
For more information about this vacancy, please contact Prof. Jo Dewulf ([email protected], +32(0)9/264 59 49) or Dr. Pieter Nachtergaele ([email protected])
Ghent University is one of the top 100 universities in the Dutch language area, with more than 44,000 students and 15,000 staff members.
Besøk arbeidsgiverens side